Experience with the vitamin-mineral complex “Pregnomama” in women with physiological pregnancy
- Authors: Gromova O.A.1,2, Pesegova E.V.3, Torshin I.Y.1,2, Tetruashvili N.K.4
-
Affiliations:
- Federal Research Center "Informatics and Management", Russian Academy of Sciences
- Center of Big Data Storage and Analysis, M.V. Lomonosov Moscow State University
- AltraVita Clinic, Clinical Center No 7
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation
- Issue: No 6 (2021)
- Pages: 122-130
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249227
- DOI: https://doi.org/10.18565/aig.2021.6.122-130
- ID: 249227
Cite item
Open Access
Access granted
Abstract
Objective. Vitamin and mineral complexes (VMCs) are effective in reducing the risk of pregnancy pathology. The effects of VMCs in physiological pregnancy have not been studied in practice. Materials and methods. Women with physiological pregnancy (n=108) were divided into two groups: 1) 54 patients who received the VMC “Pregnomama ” (a study group) and 2) 54 patients who took folic acid and potassium iodide throughout the entire pregnancy (a control group). The VMC “Pregnomama” contains 200 mg of omega-3 polyunsaturated fatty acid (PUFA): docosahexaenoic acid (DHA). The female participants’ condition was assessed at 4,12,24, and 32 weeks of pregnancy and at 42 days after its resolution, by using the data of anthropometry, biochemical blood test, and Health Status, Activity, and Mood (HSAM) and SF-36psychophysiological questionnaires. Results. By the end of the study, the study group patients compared with the controls had more HSAM scores in the sections “Activity” (+5.0, P=3.5*10-5), “Mood” (+3.8, P=8.3*10-5), “Health Status” (+3.4, P=7.5*10-7) and in the section “Physical Component of Health” of the SF-36 scale (+3.7, P=5.8* 10-5). The greatest increase in the SF-36 score was observed in the sections “Role-physical functioning” (+21.3, P=0.0002) and "Social functioning" (+8.3, P=0.0095). The increase in the values of the above indicators was associated with a rise in the omega-3 blood index (P=1.3* 10-6) primarily due to the elevated concentration of DHA (+0.48%, P=9.6* 10-6). The number of female participants with the normal omega-3 index (more than 4%) increased when taking the VMC “Pregnomama” (from 70 to 91%) and decreased in the controls (from 72 to 61%; P=0.0001). Significant dynamics of ferritin concentrations in the blood was noted already by the 12th week of pregnancy (the main group is 88.8±35.2 ng/ml, the control group is 64.0±30.3 ng/ml; P=7,8*10-5). Conclusion. The VMC “Pregnomama” is effective in maintaining the psychophysiological status during normal current pregnancy and is safe throughout the entire pregnancy.
Full Text
About the authors
Olga A. Gromova
Federal Research Center "Informatics and Management", Russian Academy of Sciences; Center of Big Data Storage and Analysis, M.V. Lomonosov Moscow State University
Email: unesco.gromova@gmail.com
Dr. Med. Sci., Professor, Science №ad of the Institute of Pharmacoinformatics, Leading Researcher of the Department of Intellectual Systems
Evgenia V. Pesegova
AltraVita Clinic, Clinical Center No 7gynecologist
Ivan Yu. Torshin
Federal Research Center "Informatics and Management", Russian Academy of Sciences; Center of Big Data Storage and Analysis, M.V. Lomonosov Moscow State UniversityPhD in Applied Mathematics, Institute of Pharmacoinformatics, Senior Researcher of the Department of Intellectual Systems
Nana K. Tetruashvili
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation
Email: n_tetruashvili@oparina4.ru
Dr. Med. Sci., Head of the 2nd Obstetrics Department of Pathology of Pregnancy
References
- Громова О.А., Торшин И.Ю., Гришина Т.Р., Малявская С.И. Омега-3-полиненасыщенные жирные кислоты в поддержке беременности и развития плода: вопросы дозирования. Гинекология. 2020; 22(5): 61-9. https://dx.doi.org/10.26442/20795696.2020.5.200424.
- Громова О.А., Торшин И.Ю. Микронутриенты и репродуктивное здоровье. Руководство. М.: ГЭОТАР-Медиа;2019. 672с.
- Громова О.А., Торшин И.Ю., Кобалава Ж.Д., Сорокина М.А., Виллевальде С.В., Галочкин С.А., Гоголева И.В., Грачева О.Н., Гришина Т.Р., Громов А.Н., Егорова Е.Ю., Калачева А.Г., Малявская С.И., Мерай И.А., Семенов В.А. Дефицит магния и гиперкоагуляционные состояния: метрический анализ данных выборки пациентов 18-50 лет лечебно-профилактических учреждений России. Кардиология. 2018; 58(4): 22-35. https://dx.doi.org/10.18087/cardio.2018.4.10106.
- Торшин И.Ю., Громова О.А., Тетруашвили Н.К., Коденцова В.М., Галустян А.Н., Курицына Н.А., Лавров Н.В., Гришина Т.Р., Лиманова О.А., Калачева А.Г., Федотова Л.Э., Лапочкина Н.П., Керимкулова Н.В., Мозговая Е.В., Тапильская Н.И., Семенов В.А., Малявская С.И., Лебедев А.В., Фролова Д.Е., Рубашкина А.Н., Рудаков К.В. Метрический анализ соотношений коморбидности между невынашиванием, эндометриозом, нарушениями менструального цикла и микронутриентной обеспеченностью в скрининге женщин репродуктивного возраста. Акушерство и гинекология. 2019; 5: 156-68. https://dx.doi.org/10.18565/aig.2019.5.156-168.
- Csaky-Szunyogh M., Vereczkey A., Urban R., Czeizel A.E. Risk and protective factors in the origin of atrial septal defect secundum--national population-based case-control study. Cent. Eur. J. Public Health. 2014; 22(1): 42-7. https://dx.doi.org/10.21101/cejph.a3824.
- Vereczkey A., Kosa Z., Csaky-Szunyogh M., Czeizel A.E. Isolated atrioventricular canal defects: birth outcomes and risk factors: a population-based Hungarian case-control study, 1980-1996. Birth Defects Res. A Clin. Mol. Teratol. 2013; 97(4): 217-24. https://dx.doi.org/10.1002/bdra.23124. PMID: 23554238.
- Приказ МЗ РФ от 01.11.2015 № 572н (редакция от 12.01.2016) «Порядок оказания медицинской помощи по профилю «акушерство и гинекология (за исключением использования вспомогательных репродуктивных технологий)».
- Министерство здравоохранения Российской Федерации. Клинические рекомендации «Нормальная беременность». М.; 2020. [Ministry of Health of the Russian Federation. Clinical guidelines "Normal pregnancy", 2020. (in Russiаn)]. Available at: https://docviewer.yandex.ru/view/0/?page=4&*=2qSdAWECHZEZBgXRuvtOdG6ivRd7InVybCI6InlhLWRpc2stcHVibGljOi8v d0hiN0UxUklIMWNyV3QxRitWaUh6QWhHa0hXTWZoYnJjaTV6dXVqbWR SL09DTGhzazBFeE12aWZTZ0IrMEZLa3EvSjZicG1SeU9Kb25UM1ZvWG 5EYWc9PSIsInRpdGxlIjoi0JrQoF%2FQndC%2B0YDQvNCw0LvRjNC90LD RjyDQsdC10YDQtdC80LXQvdC90L7RgdGC0YwucGRmIiwibm9pZnJhbWU iOmZhbHNlLCJ1aWQiOiIwIiwidHMiOjE2MjI3MTM2MDE1ODIsInl1IjoiO Tg1MzMwNjQxMTU0NTY2MTY3OSJ9
- Hastie T., Tibshirani R., Friedman J. The elements of statistical learning: data mining, inference, and prediction. Springer-Verlag; 2001. 533p.
- Лиманова О.А., Громова О.А., Торшин И.Ю., Волков А.Ю., Галустян А.Н., Гришина Т.Р., Керимкулова Н.В., Сардарян И.С., Сонина Н.П., Томилова И.К., Федотова Л.Э. Низкое потребление омега-3-ПНЖК полиненасыщенных жирных кислот и риск различных заболеваний у женщин репродуктивного возраста. Доступно по: https://www.rmj.ru/articles/ginekologiya/nizkoe-potreblenie-omega-3-polinenasyshchennykh-zhirnykh-kislot-i-risk-razlichnykh-zabolevaniy-u-zhe/
- Zhang M.M., Zou Y., Li S.M., Wang L., Sun Y.H., Shi L. et al. The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials. Transl. Psychiatry. 2020; 10(1): 193. https://dx.doi.org/10.1038/s41398-020-00886-3.
Supplementary files
